Acutus Medical, Inc.
AFIB
$0.1313
$0.024322.71%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -7.53M | 5.24M | 5.29M | 4.17M | -8.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.53M | 5.24M | 5.29M | 4.17M | -8.37M |
| Cost of Revenue | -13.15M | 8.60M | 8.06M | 6.79M | -18.65M |
| Gross Profit | 5.61M | -3.36M | -2.77M | -2.62M | 10.28M |
| SG&A Expenses | -12.21M | 7.43M | 9.28M | 9.57M | -17.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.59M | 20.82M | 24.15M | 22.47M | -55.31M |
| Operating Income | 32.06M | -15.58M | -18.86M | -18.30M | 46.94M |
| Income Before Tax | 35.97M | -13.16M | -18.35M | -16.32M | 83.57M |
| Income Tax Expenses | -12.00K | 75.00K | -- | -- | -- |
| Earnings from Continuing Operations | 35.98M | -13.24M | -18.35M | -16.32M | 83.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.77M | -13.24M | -18.35M | -16.32M | 15.11M |
| EBIT | 32.06M | -15.58M | -18.86M | -18.30M | 46.94M |
| EBITDA | 28.60M | -14.51M | -17.63M | -16.96M | 42.47M |
| EPS Basic | -1.16 | -0.45 | -0.63 | -0.57 | 0.54 |
| Normalized Basic EPS | 0.70 | -0.34 | -0.43 | -0.38 | 1.01 |
| EPS Diluted | -1.16 | -0.45 | -0.63 | -0.57 | 0.87 |
| Normalized Diluted EPS | 0.70 | -0.34 | -0.43 | -0.38 | 1.16 |
| Average Basic Shares Outstanding | 29.10M | 29.26M | 29.04M | 28.76M | 28.47M |
| Average Diluted Shares Outstanding | 29.10M | 29.26M | 29.04M | 28.76M | 37.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
